HLA-C and neoplasm: In spite of this, we were unable to specifically sort out the T cell clones recognizing the neoepitope CCT4, most likely explained by poor binding to the peptide/MHC dextramer resulting in difficulties in enriching this T cell population, leaving us with no possibility to prove the expected tumor recognition by these CCT4 specific T cells.